Logotipo del repositorio
 

COVID 19, emphysema, and secondary pulmonary fibrosis : about a case report

Vista sencilla de ítem
dc.contributor.authorGarcía-Cajiao, Alejandro
dc.contributor.authorRondón-Carvajal, Julián
dc.contributor.corporatenamePontificia Universidad Javeriana. Facultad de Medicina. Departamento de Ciencias Fisiológicasspa
dc.contributor.javerianateacherGarcía-Cajiao, Alejandro
dc.date.accessioned2023-03-13T20:49:07Z
dc.date.available2023-03-13T20:49:07Z
dc.date.created2022-03-01
dc.description.abstractenglishAssociations have been drawn between pre-existing diseases and adverse outcomes during the course of the ongoing coronavirus 2019 (COVID-19) pandemic, the disease resulting from infection with recently identified severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients who have chronic obstructive pulmonary disease with the emphysema-hyperinflated phenotype are one of the population groups with basal risk comorbidities who may have a higher probability of developing secondary pulmonary fibrosis, even in the early stages of COVID-19, potentially leading to permanent adverse functional consequences and even death. The aim of this report was to investigate this pathophysiological association in order to examine potential therapeutic targets for use during the COVID-19 pandemic that could reduce future sequelae using an illustrative clinical case and the available literature.spa
dc.description.comunidadPacientes con COVID-19spa
dc.description.esciNospa
dc.description.indexingRevista Internacional - Indexadaspa
dc.description.orcidhttps://orcid.org/0000-0003-1381-986Xspa
dc.description.orcidhttps://orcid.org/0000-0001-9804-8990spa
dc.description.quartilewosQ4spa
dc.formatPDFspa
dc.format.mimetypeapplication/pdfspa
dc.identifierhttps://eurasianjpulmonol.com/article/176spa
dc.identifier.doihttps://doi.org/10.14744/ejop_76_21spa
dc.identifier.instnameinstname:Pontificia Universidad Javerianaspa
dc.identifier.issn2148-3620 / 2148-5402 (Electrónico)spa
dc.identifier.reponamereponame:Repositorio Institucional - Pontificia Universidad Javerianaspa
dc.identifier.repourlrepourl:https://repository.javeriana.edu.cospa
dc.identifier.urihttp://hdl.handle.net/10554/63719
dc.language.isoengspa
dc.relation.citationendpage72spa
dc.relation.citationissue1spa
dc.relation.citationstartpage65spa
dc.relation.citationvolume24spa
dc.relation.ispartofjournalEurasian Journal of Pulmonologyspa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa
dc.rights.licenceAtribución-NoComercial 4.0 Internacional*
dc.source.urihttp://creativecommons.org/licenses/by-nc/4.0/*
dc.subject.keywordChronic obstructive pulmonary diseasespa
dc.subject.keywordCOVID-19spa
dc.subject.keywordEmphysemaspa
dc.subject.keywordPulmonary fibrosisspa
dc.subject.keywordSARS-CoV-2spa
dc.titleCOVID 19, emphysema, and secondary pulmonary fibrosis : about a case reportspa
dc.type.coarhttp://purl.org/coar/resource_type/c_93fcspa
dc.type.hasversionhttp://purl.org/coar/version/c_ab4af688f83e57aa
dc.type.localArtículo de revistaspa

Archivos

Bloque original
Mostrando 1 - 1 de 1
Miniatura
Nombre:
COVID 19, emphysema, and secondary pulmonary fibrosis About a case report.pdf
Tamaño:
726.86 KB
Formato:
Adobe Portable Document Format
Descripción:
Artículo
Descargar
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
2.54 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar

Colecciones

Artículos